Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC). (December 2016)

Record Type:
Journal Article
Title:
Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC). (December 2016)
Main Title:
Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)
Authors:
Meric-Bernstam, F.
Tannir, N.
Harding, J.
Voss, M.
Mier, J.
DeMichele, A.
Munster, P.
Patel, M.
Iliopoulos, O.
Owonikoko, T.
Whiting, S.
Orford, K.
Bennett, M.
Carvajal, R.
McKay, R.
Fan, A.
Telli, M.
Infante, J.
Abstract:
Is Part Of:
European journal of cancer. Volume 69(2016)supplement 1
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Issue Display:
Volume 69, Issue 2016 (2016)
Year:
2016
Volume:
69
Issue:
2016
Issue Sort Value:
2016-0069-2016-0000
Page Start:
S12
Page End:
S13
Publication Date:
2016-12
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(16)32626-0 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2628.xml